Calendar Mankind Pharma Limited

Equities

MANKIND

INE634S01028

Pharmaceuticals

Delayed NSE India S.E. Other stock markets 01:16:13 2025-12-11 EST			5-day change	1st Jan Change
2,165.80 ^INR	+0.79%		-1.85%	-24.82%

12-10	Mankind Pharma receives tax penalty of 153.2 million rupees	RE
12-01	EQT Shows Interest in Vitabiotics - ET	FW

Chart calendar Mankind Pharma Limited

54a4c.BCpTkR2x3fpqi9XBr2CM6KDDc41lDGImlbRT70MHEak.R1xr_EjAspk94YyvzBq-guKsMOZXXyVP94MFqnJmcNpdSQD3U4WriyCmtg~863548451201ff46f5fb569116424d18

Upcoming events on Mankind Pharma Limited

2026-02-03	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-06-01	Q4 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-08-04	Q1 2027 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-11-10	Q2 2027 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

Past events on Mankind Pharma Limited

2025-11-17	Avendus Spark INDX Investor Conference
2025-11-11	Anand Rathi Flagship G-200 Conference
2025-11-06	Q2 2026 Earnings Call
2025-11-06	Q2 2026 Earnings Release
2025-09-22	J.P. Morgan India Conference
2025-09-16	Jefferies India Forum
2025-09-01	Ashwamedh Elara India Dialogue Conference
2025-08-31	Motilal Oswal Global Investor Conference
2025-08-20	Systematix Pharma & Healthcare Conference
2025-08-19	Antique Flagship India Conference
2025-08-07	Annual General Meeting
2025-08-01	Q1 2026 Earnings Call
2025-07-31	Q1 2026 Earnings Release
2025-06-23	IIFL Invest India Conference
2025-06-22	Kotak India Corporate Day
2025-06-01	BofA Changing Growth Contours Conference
2025-05-27	B&K Securities Trinity India Investor Conference
2025-05-26	Nirmal Bang Investor Conference
2025-05-21	Q4 2025 Earnings Call
2025-05-21	Q4 2025 Earnings Release

Past dividends on Mankind Pharma Limited

2025-08-07

Interim Payment 1 INR

Annual results

Fiscal Period	March	2023	2024	2025	2026	2027	2028
Net sales Million INR	Released Forecast Spread	87 494 86 065 1.66%	103 348 103 159 0.18%	122 074 122 917 -0.69%	146 049	164 405	183 423
EBITDA Million INR	Released Forecast Spread	19 006 18 418 3.19%	25 351 24 934 1.67%	30 179 31 841 -5.22%	36 662	43 162	49 512
EBIT Million INR	Released Forecast Spread	15 747 15 200 3.6%	21 368 21 032 1.6%	23 967 25 717 -6.8%	28 031	34 138	39 807
Earnings before Tax (EBT) Million INR	Released Forecast Spread	16 712 12 339 35.44%	23 994 23 312 2.92%	25 163 24 719 1.8%	25 455	33 299	40 995
Net income Million INR	Released Forecast Spread	12 819 12 194 5.12%	19 129 18 298 4.54%	19 910 19 389 2.68%	20 150	25 925	32 118
EPS INR	Released Forecast Spread	32,0 30,3 5.72%	47,7 45,7 4.28%	49,2 47,5 3.6%	48,7	62,7	77,7
Announcement Date		30/05/23	15/05/24	21/05/25	-

Quarterly results

Fiscal Period	March	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales Million INR	Released Forecast Spread	27 081 26 998 0.31%	26 070 24 214 7.66%	24 411 24 228 0.76%	28 934 29 279 -1.18%	30 765 30 462 1%	32 300 31 972 1.03%	30 794 30 904 -0.36%	35 704 36 003 -0.83%	37 192	36 256	33 748
EBITDA Million INR	Released Forecast Spread	6 826 6 987 -2.3%	6 065 5 822 4.18%	5 911 5 585 5.84%	6 818 7 510 -9.21%	8 500 7 839 8.44%	8 298 8 202 1.17%	6 832 7 874 -13.24%	8 468 9 025 -6.17%	9 493	9 173	8 032
EBIT Million INR	Released Forecast Spread	5 862 5 706 2.73%	4 968 4 347 14.28%	4 864 4 155 17.07%	5 740 6 254 -8.22%	7 444 6 416 16.03%	6 375 5 194 22.74%	4 523 5 730 -21.06%	6 281 5 996 4.75%	7 087
Earnings before Tax (EBT) Million INR	Released Forecast Spread	6 410 6 229 2.9%	5 623 4 984 12.84%	5 716 4 776 19.69%	6 676 6 902 -3.27%	8 493 7 118 19.33%	4 973 5 801 -14.26%	5 154 4 399 17.16%	5 405 5 670 -4.68%	6 217	6 340	5 369
Net income Million INR	Released Forecast Spread	5 010 5 176 -3.19%	4 538 4 194 8.19%	4 712 3 823 23.26%	5 365 5 768 -6.98%	6 535 5 909 10.59%	3 802 4 646 -18.16%	4 208 3 497 20.31%	4 383 4 473 -2.01%	4 853	5 219	4 367
EPS INR	Released Forecast Spread	12,5 11,0 13.55%	11,3 9,87 14.63%	11,7 9,35 25.56%	13,4 14,3 -6.5%	16,3 14,3 13.65%	9,44 11,6 -18.9%	10,2 8,98 13.43%	10,6 10,7 -0.47%	12,1	13,0	10,9
Announcement Date		31/10/23	31/01/24	15/05/24	31/07/24	05/11/24	23/01/25	21/05/25	31/07/25	-	-	-

Upcoming sector events for Mankind Pharma Limited

2026-01-05	HISAMITSU PHARMACEUTICAL CO., INC.	Q3 2025 Earnings Release	Add to your calendar Google Apple ICS format
2026-01-11	TILRAY BRANDS, INC.	Q2 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-01-15	SUPRIYA LIFESCIENCE LIMITED	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-01-20	JOHNSON & JOHNSON	Q4 2025 Earnings Release	Add to your calendar Google Apple ICS format
2026-01-20	HANALL BIOPHARMA CO., LTD.	Q4 2025 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-01-21	LAURUS LABS LIMITED	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-01-21	ALIVUS LIFE SCIENCES LIMITED	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-01-21	TORRENT PHARMACEUTICALS LIMITED	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-01-22	DR. REDDY'S LABORATORIES LIMITED	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format
2026-01-26	GRANULES INDIA LIMITED	Q3 2026 Earnings Release (Projected)	Add to your calendar Google Apple ICS format

More events

Past sector events for Mankind Pharma Limited

2025-12-09	MEDINCELL S.A.	Q2 2026 Earnings Release
2025-12-09	CENTER LABORATORIES, INC.	November 2025 Sales and Revenue Release
2025-12-09	BORA PHARMACEUTICALS CO., LTD.	November 2025 Sales and Revenue Release
2025-12-05	TTY BIOPHARM COMPANY LIMITED	November 2025 Sales and Revenue Release
2025-11-30	INVENTAGE LAB, INC.	Q3 2025 Earnings Release
2025-11-27	DOTTIKON ES HOLDING AG	Q2 2026 Earnings Release
2025-11-19	CSPC PHARMACEUTICAL GROUP LIMITED	Q3 2025 Earnings Release
2025-11-14	SEQUENT SCIENTIFIC LIMITED	Q2 2026 Earnings Release
2025-11-14	NATCO PHARMA LIMITED	Q2 2026 Earnings Release
2025-11-14	BAVARIAN NORDIC A/S	Q3 2025 Earnings Release